Ruey-min Lee

Statistics

Publications

Citations

937

H-Index

Active since

2013

Affiliations

The Barbara Ann Karmanos Cancer Institute(Current)

Ruey-min Lee is an author at The Barbara Ann Karmanos Cancer Institute specializing in metastatic disease treatment, cancer pharmacology, and oncology pharmacotherapy.

Publications per year

2013–2014

Publications

Safety and activity of alectinib against systemic disease and brain metastases in patients with crizotinib-resistant ALK-rearranged non-small-cell lung cancer (AF-002JG): results from the dose-finding portion of a phase 1/2 study

Shirish M. Gadgeel, Leena Gandhi, Gregory J. Riely et al. · The Lancet Oncology · 2014 · 695 citations

Medicine, Oncology, Pharmacology +16

Results of an International Randomized Phase III Trial of the Mammalian Target of Rapamycin Inhibitor Ridaforolimus Versus Placebo to Control Metastatic Sarcomas in Patients After Benefit From Prior Chemotherapy

George D. Demetri, Sant P. Chawla, Isabelle Ray‐Coquard et al. · Journal of Clinical Oncology · 2013 · 242 citations

Medicine, Oncology, Pharmacology +17

1–2 of 2